Abstract
References
Articles referenced by this article (23)
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.
J Biol Chem, (15):9158-9167 1998
MED: 9535906
Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.
Mol Cell, (2):259-269 2002
MED: 12191472
Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.
J Biol Chem, (19):20211-20220 2004
MED: 14981075
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
J Neurosci, (18):7862-7872 2002
MED: 12223539
Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity.
J Cell Biol, (4):647-656 2005
MED: 15911879
A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.
Mol Cell, (6):853-865 2004
MED: 15383276
p21-activated kinase 1 promotes soluble mutant huntingtin self-interaction and enhances toxicity.
Hum Mol Genet, (6):895-905 2007
MED: 18065495
PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.
Biochem J, (Pt 2):201-214 2005
MED: 15548136
Show 10 more references (10 of 23)
Citations & impact
Impact metrics
Citations of article over time
Article citations
The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: From genotype to phenotype.
Front Neurosci, 17:1123784, 02 Mar 2023
Cited by: 2 articles | PMID: 36937657 | PMCID: PMC10017488
Review Free full text in Europe PMC
Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.
J Huntingtons Dis, 11(3):243-267, 01 Jan 2022
Cited by: 8 articles | PMID: 35871359 | PMCID: PMC9484122
Unconventional secretion of α-Crystallin B requires the Autophagic pathway and is controlled by phosphorylation of its serine 59 residue.
Sci Rep, 9(1):16892, 15 Nov 2019
Cited by: 20 articles | PMID: 31729431 | PMCID: PMC6858465
Polyglutamine tracts regulate beclin 1-dependent autophagy.
Nature, 545(7652):108-111, 26 Apr 2017
Cited by: 188 articles | PMID: 28445460 | PMCID: PMC5420314
Dbo/Henji Modulates Synaptic dPAK to Gate Glutamate Receptor Abundance and Postsynaptic Response.
PLoS Genet, 12(10):e1006362, 13 Oct 2016
Cited by: 7 articles | PMID: 27736876 | PMCID: PMC5065118
Go to all (11) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
Neurosci Lett, 431(1):45-50, 17 Nov 2007
Cited by: 32 articles | PMID: 18078716
p21-activated kinase 1 promotes soluble mutant huntingtin self-interaction and enhances toxicity.
Hum Mol Genet, 17(6):895-905, 07 Dec 2007
Cited by: 37 articles | PMID: 18065495
Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation.
J Biol Chem, 286(28):25108-25117, 25 Mar 2011
Cited by: 42 articles | PMID: 21454471 | PMCID: PMC3137084
Are there multiple pathways in the pathogenesis of Huntington's disease?
Philos Trans R Soc Lond B Biol Sci, 354(1386):995-1003, 01 Jun 1999
Cited by: 29 articles | PMID: 10434298 | PMCID: PMC1692615
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Medical Research Council (2)
Modifiers of polyglutamine disease pathogenesis
Professor David Rubinsztein, University of Cambridge
Grant ID: G0600194
Modifiers of polyglutamine disease pathogenesis
Professor David Rubinsztein, University of Cambridge
Grant ID: G0600194(77639)
Wellcome Trust (1)
Therapeutic approaches for codon reiteration diseases
Professor David Rubinsztein, University of Cambridge
Grant ID: 064354